With 1.92 million shares changed hands, the volume of the stock remained heavier than its average volume of 1.84 million shares. During the session, the Specialty Chemicals company that operates in wider Basic Materials sector, reached to the highest price of $34.755 whereas the lowest price it dropped to was $33.99. The 52-week range on AXTA shows that it touched its highest point at $41.65 and its lowest point at $30.40 during that stretch. It currently has a 1-year price target of $43.94. Beta for the stock currently stands at 1.46.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of AXTA was up-trending over the past week, with a rise of 0.59%, but this was down by -14.47% over a month. Three-month performance dropped to -4.55% while six-month performance rose 0.80%. The stock gained 3.79% in the past year, while it has lost -0.03% so far this year. A look at the trailing 12-month EPS for AXTA yields 1.48 with Next year EPS estimates of 2.38. For the next quarter, that number is 0.51. This implies an EPS growth rate of 37.08% for this year and 10.36% for next year. EPS is expected to grow by 20.90% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 7.16%.
Float and Shares Shorts:
At present, 218.00 million AXTA shares are outstanding with a float of 217.22 million shares on hand for trading. On 2024-12-13, short shares totaled 4.41 million, which was 202.0 higher than short shares on 1731628800. In addition to Mr. Chrishan Anthon Sebastian Villavarayan as the firm’s CEO, President & Director, Mr. Carl D. Anderson II serves as its Senior VP & CFO.
Institutional Ownership:
Through their ownership of 1.02773 of AXTA’s outstanding shares, institutional investors have minority control over the company.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2024-09-30, AXTA reported revenue of $1320000000.0 and operating income of $193000000.0. The EBITDA in the recently reported quarter was $267000000.0 and diluted EPS was $0.46.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for AXTA since 11 analysts follow the stock currently. There are 7 analysts who recommend BUY ratings, while 1 suggest SELL ratings. Of the remaining analysts, 3 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With AXTA analysts setting a high price target of 51.0 and a low target of 39.0, the average target price over the next 12 months is 43.81947. Based on these targets, AXTA could surge 49.08% to reach the target high and rise by 14.0% to reach the target low. Reaching the average price target will result in a growth of 28.09% from current levels.
Analysts have provided yearly estimates in a range of $2.20218 being high and $2.10208 being low. For AXTA, this leads to a yearly average estimate of $2.15213.
